Literature DB >> 15803371

Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.

Mariarita Santi1, Martha Quezado, Rubin Ronchetti, Elisabeth J Rushing.   

Abstract

Few studies have yielded reliable data that distinguish between ependymal neoplasms based on molecular genetic attributes. The present study utilizes chromogenic in situ hybridization (CISH), a relatively recent hybridization technique, to retrospectively examine chromosome 7-copy number in pediatric and adult ependymomas. Of the 27 hybridizations, polysomy of chromosome 7 was detected in 10 out of 15 (66%) adult ependymomas, and in only three out of 12 (25%) pediatric lesions. All myxopapillary ependymomas showed polysomy. The remaining tumors were diploid. The authors conclude that (1) there are distinct genetic subsets of ependymoma, in particular, increases in copy number of chromosome 7 are almost exclusively found in myxopapillary ependymoma, and that (2) CISH is a rapid and sensitive method of stratifying morphological variants of ependymoma and potentially other central nervous system (CNS) tumors. These results encourage further investigations with CISH on a larger scale to determine its merit as an ancillary diagnostic and prognostic tool.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803371     DOI: 10.1007/s11060-004-3117-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.

Authors:  J K Rummukainen; T Salminen; J Lundin; H Joensuu; J J Isola
Journal:  Lab Invest       Date:  2001-11       Impact factor: 5.662

2.  Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.

Authors:  Peter H Wessels; Albert Twijnstra; Alfons G H Kessels; Bela Krijne-Kubat; Paul H Theunissen; Monique I J Ummelen; Frans C S Ramaekers; Anton H Hopman
Journal:  Genes Chromosomes Cancer       Date:  2002-03       Impact factor: 5.006

3.  Chromosome abnormalities in low-grade central nervous system tumors.

Authors:  C A Griffin; P P Long; B S Carson; H Brem
Journal:  Cancer Genet Cytogenet       Date:  1992-05

4.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.

Authors:  E P Arnoldus; L B Wolters; J H Voormolen; S G van Duinen; A K Raap; M van der Ploeg; A C Peters
Journal:  J Neurosurg       Date:  1992-06       Impact factor: 5.115

6.  Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.

Authors:  Pratima K Singh; David H Gutmann; Christine E Fuller; Irene F Newsham; Arie Perry
Journal:  Mod Pathol       Date:  2002-05       Impact factor: 7.842

7.  Isochromosome 1q as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics.

Authors:  M Granzow; S Popp; S Weber; B Schoell; H Holtgreve-Grez; L Senf; D Hager; J Boschert; W Scheurlen; A Jauch
Journal:  Cancer Genet Cytogenet       Date:  2001-10-01

8.  Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification.

Authors:  C H Rickert; W Paulus
Journal:  Childs Nerv Syst       Date:  2001-09       Impact factor: 1.475

9.  Interphase cytogenetic (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy.

Authors:  A Perry; V Tonk; D D McIntire; C L White
Journal:  Am J Clin Pathol       Date:  1997-08       Impact factor: 2.493

10.  Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome.

Authors:  G Peiró; D Mayr; P Hillemanns; U Löhrs; J Diebold
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

View more
  6 in total

Review 1.  Molecular genetics of pediatric central nervous system tumors.

Authors:  Nicole J Ullrich; Scott L Pomeroy
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 2.  Spinal cord ependymoma: a review of the literature and case series of ten patients.

Authors:  Emma Celano; Arsalaan Salehani; James G Malcolm; Erik Reinertsen; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2016-05-06       Impact factor: 4.130

Review 3.  Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.

Authors:  Isaac Yang; Daniel T Nagasawa; Won Kim; Marko Spasic; Andy Trang; Daniel C Lu; Neil A Martin
Journal:  J Clin Neurosci       Date:  2012-04-18       Impact factor: 1.961

4.  Subependymoma revisited: clinicopathological evaluation of 83 cases.

Authors:  Elisabeth J Rushing; Patrick B Cooper; Martha Quezado; Maria Begnami; Ana Crespo; James G Smirniotopoulos; James Ecklund; Cara Olsen; Mariarita Santi
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

5.  Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.

Authors:  Maria D Begnami; Mauricio Palau; Elisabeth J Rushing; Mariarita Santi; Martha Quezado
Journal:  Hum Pathol       Date:  2007-05-23       Impact factor: 3.466

6.  Unique molecular characteristics of pediatric myxopapillary ependymoma.

Authors:  Valerie N Barton; Andrew M Donson; Bette K Kleinschmidt-DeMasters; Diane K Birks; Michael H Handler; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2009-09-10       Impact factor: 6.508

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.